1. 1476PRole of immunotherapy (I) for advanced, pre-treated, non-squamous NSCLC (APNS-NSCLC): Preliminary data of a pooled analysis with network meta-analysis. (23rd October 2018) Authors: Cherubini, C; Papi, M; Gianni, L; Gianni, C; Nicoletti, S V L; Fantini, M; Lazzari Agli, L A; Tassinari, D Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1846PRole of TP53 mutations in relation to response to anti-ALK agents in EML4-ALK-translocated NSCLC patients. (23rd October 2018) Authors: Canale, M; Delmonte, A; Dazzi, C; Gamboni, A; Casanova, C; Papi, M; Mariotti, M; De Luigi, N; Burgio, M A; Minuti, G; Calistri, D; Bonafè, M; Crinò, L; Ulivi, P Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Recent advances in superhydrophobic surfaces and their relevance to biology and medicine. (4th February 2016) Authors: Ciasca, G; Papi, M; Businaro, L; Campi, G; Ortolani, M; Palmieri, V; Cedola, A; De Ninno, A; Gerardino, A; Maulucci, G; De Spirito, M Journal: Bioinspiration & biomimetics Issue: Volume 11:Number 1(2016:Mar.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗